209 related articles for article (PubMed ID: 7770635)
1. Recombinant human chromogranin A: expression, purification and characterization of the N-terminal derived peptides.
Taupenot L; Remacle JE; Helle KB; Aunis D; Bader MF
Regul Pept; 1995 Mar; 56(1):71-88. PubMed ID: 7770635
[TBL] [Abstract][Full Text] [Related]
2. Vasostatins, comprising the N-terminal domain of chromogranin A, suppress tension in isolated human blood vessel segments.
Aardal S; Helle KB; Elsayed S; Reed RK; Serck-Hanssen G
J Neuroendocrinol; 1993 Aug; 5(4):405-12. PubMed ID: 8401564
[TBL] [Abstract][Full Text] [Related]
3. Intracellular and extracellular processing of chromogranin A. Determination of cleavage sites.
Metz-Boutigue MH; Garcia-Sablone P; Hogue-Angeletti R; Aunis D
Eur J Biochem; 1993 Oct; 217(1):247-57. PubMed ID: 8223562
[TBL] [Abstract][Full Text] [Related]
4. Characterization of natural vasostatin-containing peptides in rat heart.
Glattard E; Angelone T; Strub JM; Corti A; Aunis D; Tota B; Metz-Boutigue MH; Goumon Y
FEBS J; 2006 Jul; 273(14):3311-21. PubMed ID: 16857014
[TBL] [Abstract][Full Text] [Related]
5. Processing of chromogranin B in bovine adrenal medulla. Identification of secretolytin, the endogenous C-terminal fragment of residues 614-626 with antibacterial activity.
Strub JM; Garcia-Sablone P; Lonning K; Taupenot L; Hubert P; Van Dorsselaer A; Aunis D; Metz-Boutigue MH
Eur J Biochem; 1995 Apr; 229(2):356-68. PubMed ID: 7744058
[TBL] [Abstract][Full Text] [Related]
6. Effects of calcium on recombinant bovine chromogranin A.
Angeletti RH; Ali G; Shen N; Gee P; Nieves E
Protein Sci; 1992 Dec; 1(12):1604-12. PubMed ID: 1304892
[TBL] [Abstract][Full Text] [Related]
7. Primary sequence characterization of catestatin intermediates and peptides defines proteolytic cleavage sites utilized for converting chromogranin a into active catestatin secreted from neuroendocrine chromaffin cells.
Lee JC; Taylor CV; Gaucher SP; Toneff T; Taupenot L; Yasothornsrikul S; Mahata SK; Sei C; Parmer RJ; Neveu JM; Lane WS; Gibson BW; O'Connor DT; Hook VY
Biochemistry; 2003 Jun; 42(23):6938-46. PubMed ID: 12795588
[TBL] [Abstract][Full Text] [Related]
8. Vasoinhibitory activity of synthetic peptides from the amino terminus of chromogranin A.
Angeletti RH; Aardal S; Serck-Hanssen G; Gee P; Helle KB
Acta Physiol Scand; 1994 Sep; 152(1):11-9. PubMed ID: 7810329
[TBL] [Abstract][Full Text] [Related]
9. Secretion from chromaffin cells is controlled by chromogranin A-derived peptides.
Simon JP; Bader MF; Aunis D
Proc Natl Acad Sci U S A; 1988 Mar; 85(5):1712-6. PubMed ID: 3422758
[TBL] [Abstract][Full Text] [Related]
10. Chromogranin A epitopes: clues from synthetic peptides and peptide mapping.
Gill BM; Barbosa JA; Hogue-Angeletti R; Varki N; O'Connor DT
Neuropeptides; 1992 Feb; 21(2):105-18. PubMed ID: 1372966
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of N-terminal chromogranin A and chromogranin B in mammals by region-specific radioimmunoassays and chromatographic separation methods.
Stridsberg M; Angeletti RH; Helle KB
J Endocrinol; 2000 Jun; 165(3):703-14. PubMed ID: 10828855
[TBL] [Abstract][Full Text] [Related]
12. PC12 cells show immunoreactivity to a number of proteins and peptides, including vasostatin.
Cunningham RT; Pogue KM; Curry WJ; Johnston CF; Buchanan KD
Peptides; 1996; 17(8):1297-301. PubMed ID: 8971922
[TBL] [Abstract][Full Text] [Related]
13. Bovine parathyroid glands secrete a 26-kDa N-terminal fragment of chromogranin-A which inhibits parathyroid cell secretion.
Drees BM; Rouse J; Johnson J; Hamilton JW
Endocrinology; 1991 Dec; 129(6):3381-7. PubMed ID: 1954912
[TBL] [Abstract][Full Text] [Related]
14. The vasoinhibitory activity of bovine chromogranin A fragment (vasostatin) and its independence of extracellular calcium in isolated segments of human blood vessels.
Aardal S; Helle KB
Regul Pept; 1992 Sep; 41(1):9-18. PubMed ID: 1455014
[TBL] [Abstract][Full Text] [Related]
15. Chromogranin A: posttranslational modifications in secretory granules.
Barbosa JA; Gill BM; Takiyyuddin MA; O'Connor DT
Endocrinology; 1991 Jan; 128(1):174-90. PubMed ID: 1986917
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of chromogranin A-derived peptides in bovine gut, pancreas and adrenal medulla.
Watkinson A; Jönsson AC; Davison M; Young J; Lee CM; Moore S; Dockray GJ
Biochem J; 1991 Jun; 276 ( Pt 2)(Pt 2):471-9. PubMed ID: 1710890
[TBL] [Abstract][Full Text] [Related]
17. Chromostatin, a 20-amino acid peptide derived from chromogranin A, inhibits chromaffin cell secretion.
Galindo E; Rill A; Bader MF; Aunis D
Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1426-30. PubMed ID: 1996343
[TBL] [Abstract][Full Text] [Related]
18. Chromogranin A from bovine adrenal medulla: molecular characterization of glycosylations, phosphorylations, and sequence heterogeneities by mass spectrometry.
Bauer SH; Zhang XY; Van Dongen W; Claeys M; Przybylski M
Anal Biochem; 1999 Oct; 274(1):69-80. PubMed ID: 10527498
[TBL] [Abstract][Full Text] [Related]
19. Parastatin (porcine chromogranin A347-419), a novel chromogranin A-derived peptide, inhibits parathyroid cell secretion.
Fasciotto BH; Trauss CA; Greeley GH; Cohn DV
Endocrinology; 1993 Aug; 133(2):461-6. PubMed ID: 8344192
[TBL] [Abstract][Full Text] [Related]
20. Peptides from the N-terminal domain of chromogranin A (vasostatins) exert negative inotropic effects in the isolated frog heart.
Tota B; Mazza R; Angelone T; Nullans G; Metz-Boutigue MH; Aunis D; Helle KB
Regul Pept; 2003 Jul; 114(2-3):123-30. PubMed ID: 12832100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
